Aytu BioPharma (AYTU) S-4/A Registration of securities issued in business combination transactions (amended)

Exhibit 23.7

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Amendment No. 1 to Form S-4 Registration Statement (File No. 333-252450) of the Form 8-K Current Report dated February 14, 2020 which incorporates by reference our report dated April 1, 2019, relating to the consolidated financial statements of Innovus Pharmaceuticals, Inc., appearing in the Annual Report on Form 10-K of Innovus Pharmaceuticals, Inc. for the years ended December 31, 2018 and 2017.

We also consent to the reference to us under the heading “Experts” in the prospectus, which is part of such registration statement.

/s/ Hall & Company Certified Public Accountants & Consultants, Inc.

Irvine, CA

February 8, 2021